The U.S. Food and Drug Administration (FDA) is announcing a virtual public meeting to discuss proposed recommendations for the reauthorization of the Medical Device User Fee Amendments (MDUFA) for fiscal years 2023 through 2027. The current legislative authority for MDUFA expires on September 30, 2022. New legislation is required for the FDA to continue to collect user fees for the medical device program in future fiscal years.
Date: Tuesday, April 19, 2022
Time: 12 p.m. to 4:30 p.m. ET
Location: The meeting will be webcast only
Registration Deadline: Monday, April 18, 2022, by 4 p.m. ET
Important Deadlines
April 11, 2022: Request special accommodations for the meeting.
April 11, 2022: Request to make oral presentations during the public comment session or a specific session.
April 18, 2022: Register to attend the meeting.
April 21, 2022: Submit written comments to the docket (FDA-2020-N-0907).
MDUFA V Public Meeting
As a reminder, the April 19 meeting on MDUFA V will be held by webcast only beginning at 12:00 p.m. ET. Registration is currently open.
Questions?
If you have questions about this public meeting, contact Mimi Nguyen at MDUFAVReauthorization@fda.hhs.gov.
